ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Knudson To Head Fox Chase Center

November 21, 1980

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

DCE director Adamson To Retire August 31

June 3, 1994

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994